Intrapleural fibrinolytics for pleural infection: Optimizing dosing for future trials - reply

被引：2
|
作者：
Levinson, Gary M. [1 ]
Pennington, Daniel W. [1 ]
机构：
[1] Mercy Med Ctr N Iowa, Dept Pulm Med, Mason City, IA 50401 USA
来源：
MAYO CLINIC PROCEEDINGS | 2007年 / 82卷 / 08期
关键词：
D O I：
10.4065/82.8.1016-a
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1016 / 1017
页数：2
相关论文
共 50 条
  • [41] Intrapleural tPA increases pleural fluid output in pleural infection, independent of chest X-ray opacification
    Wrightson, John
    Corcoran, John
    Psallidas, Ioannis
    Hallifax, Robert
    Maskell, Nick
    Rahman, Najib
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [42] Effects of Concurrent Dosing on the Efficacy of Deoxyribonuclease in the Treatment of Pleural Infection
    Pathak, Vikas
    Adhikari, Lukash
    Zhou, Christine
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [43] Optimizing intrapleural bevacizumab dosing in non-small-cell lung cancer-mediated malignant pleural effusion: less is more (vol 14, pg 2131, 2018)
    Chen, Dawei
    Song, Xinyu
    Zhang, Yan
    Kong, Li
    Wang, Haiyong
    Yu, Jinming
    FUTURE ONCOLOGY, 2021, 17 (11) : 1441 - 1443
  • [44] Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection The Alteplase Dose Assessment for Pleural Infection Therapy Project
    Popowicz, Natalia
    Bintcliffe, Oliver
    De Fonseka, Duneesha
    Blyth, Kevin G.
    Smith, Nicola A.
    Piccolo, Francesco
    Martin, Geoffrey
    Wong, Donny
    Edey, Anthony
    Maskell, Nick
    Lee, Y. C. Gary
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (06) : 929 - 936
  • [45] Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection
    Kheir, Fayez
    Cheng, George
    Rivera, Estefania
    Folch, Alejandro
    Folch, Erik
    Fernandez-Bussy, Sebastian
    Keyes, Colleen
    Parikh, Mihir
    Channick, Colleen
    Chee, Alex
    Majid, Adnan
    JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY, 2018, 25 (02) : 125 - 131
  • [46] An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection
    Lau, Estee P. M.
    Eshraghi, Matin
    Dootson, Kirstie
    Yeoh, Cindy
    Phu, Wint Ywe
    Lee, Y. C. Gary
    Popowicz, Natalia D.
    ERJ OPEN RESEARCH, 2022, 8 (01)
  • [47] Short-course modified regimen intrapleural alteplase and pulmozyme (DNase) in pleural infection
    Faisal, M.
    Farhan, R.
    Cheong, X. K.
    Ng, B. H.
    Nuratiqah, N.
    Andrea, Ban Y. L.
    RESPIRATORY MEDICINE CASE REPORTS, 2020, 31
  • [48] Factors Affecting Success Of Intrapleural Treatment Using Combination Tpa And Dnase For Pleural Infection
    Wrightson, J. M.
    Corcoran, J. P.
    Hallifax, R.
    Maskell, N. A.
    Psallidas, I.
    Rahman, N. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [49] A multicentre study evaluating bleeding risk with intrapleural enzyme therapy in pleural infection (RETROLYSIS)
    Bedawi, Eihab
    Rahman, Najib
    Yarmus, Lonny
    Akulian, Jason
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [50] BTS guidelines for the management of pleural infection - Reply
    Davis, RJO
    Davies, CWH
    Gleeson, FV
    THORAX, 2004, 59 (02) : 178 - 178
12345